Mark Rothera Net Worth & Insider Trades

Mark Rothera - Chief Commercial Officer, Ptc Therapeutics, Inc

As of May 25, 2017

What is Mark Rothera's Net Worth?

The current estimated net worth of Ptc Therapeutics, Inc's Chief Commercial Officer, Mark Rothera, is estimated to be about $5.9M . Mark Rothera owns about 14,341 units of Ptc Therapeutics, Inc common stock. In the last 3 years at Ptc Therapeutics, Inc, Mark Rothera has sold an estimated value of $5.11M worth.

What is Mark Rothera's Past Insider Trading?

Mark Rothera's largest purchase order was 32,000 units , worth over $347.2K on February 25, 2015. Mark Rothera's largest sale order was 35,000 units , worth over $2.38M on February 25, 2015. In total, Mark Rothera has made about 22 transactions over 3 years of their time at Ptc Therapeutics, Inc. Mark Rothera usually trades in January, with the busiest year in 2015. The most recent transaction was a purchase order of 2,000 units , worth over $12.46K on March 7, 2016.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Mark Rothera's' Mailing Address?

  • Mailing address is C/o Aegerion Pharmaceuticals, Inc. 101 Main Street, Suite 1850 Cambridge MA 02142 MA

What are Ptc Therapeutics, Inc's Past Insider Trades?

Ptc Therapeutics, Inc's most recent insider trade came on September 22, 2022 by Elliott Mark Boulding who sold 1,176 units worth $64.68K . In the last 9 years, insiders at Ptc Therapeutics, Inc have sold an estimated value of $159.71M and bought an estimated value of $101.28M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Walter Stuart Peltz, CHIEF EXECUTIVE OFFICER,  Gregory Neil Almstead, Chief Technical Ops Officer,  and Elliott Mark Boulding, EXEC. VP AND CLO .

PTC THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1